A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery

Clinical trial NCT07694375 · RECRUITING

Trial details

NCT number: NCT07694375
Sponsor: Caravel Oculus Pty Ltd
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Corneal Endothelial Cell Loss Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgery

Start date: 2026-07-28
Primary completion: 2027-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.